The present disclosure relates generally to blood monitoring equipment used during cardiac surgery, for example.
During surgery, a patient's vascular system may be connected to an extracorporeal circuit that temporarily replaces the function of the heart and lungs. An extracorporeal blood circuit (ECC) may include, among other features, a pump to replace heart functions, and an oxygenation device to replace lung functions. The present disclosure relates to blood monitoring systems, methods, and devices that may be used as part as an extracorporeal blood circuit.
In Example 1, a system includes a cuvette including a cuvette body forming a substantially planar exterior surface and having a sensor window defined within the substantially planar exterior surface. The cuvette further includes a probe retention structure extending from the cuvette body. The system includes a probe with a probe body and a protrusion that is removably coupled to the probe retention structure.
In Example 2, the system of Example 1, wherein the protrusion is coupled to a spring-loaded assembly at least partially positioned within the probe body.
In Example 3, the system of any of Examples 1-2, wherein the cuvette further include at least one pin extending from the cuvette body, the at least one pin mechanically coupled to the probe.
In Example 4, the system of any of Examples 1-3, wherein the probe further includes sensors positioned in alignment with the sensor window.
In Example 5, the system of Example 4, wherein the sensors include an optical sensor.
In Example 6, the system of any of Examples 1-5, wherein the probe retention structure forms an indent with at least a portion of the protrusion extending therein.
In Example 7, the system of any of Examples 1-6, wherein the probe retention structure forms an aperture with at least a portion of the protrusion extending therein.
In Example 8, the system of Example 1, wherein the protrusion is integrally formed with the probe body.
In Example 9, the system of any of Examples 1-8, wherein the probe retention structure is flexible.
In Example 10, the system of any of Examples 1-9, wherein the protrusion is deformable.
In Example 11, a cuvette includes a cuvette body including a sensor window frame, a sensor window positioned in the sensor window frame, and a window retainer mechanically coupling the sensor window to the cuvette body.
In Example 12, the cuvette of Example 11, wherein the cuvette body forms at least two teeth mechanically coupled to the window retainer.
In Example 13, the cuvette of any of Examples 11-12, further including an O-ring positioned between the sensor window and the sensor window frame.
In Example 14, the cuvette of any of Examples 11-13, wherein the sensor window includes a fluorescent coating.
In Example 15, the cuvette of any of Examples 11-14, wherein the sensor window comprises polyvinilydenefluoride.
In Example 16, the cuvette of any of Examples 11-15, wherein the sensor window has a biocompatible film coating on a surface facing a central bore formed by the cuvette body.
In Example 17, the cuvette of any of Examples 1-16, wherein the cuvette body includes an exterior surface that is substantially planar, and wherein the single sensor window frame is defined in the substantially planar surface.
In Example 18, the cuvette of any of Examples 1-17, wherein the probe retention structure is positioned near an end of the cuvette body.
In Example 19, the cuvette of Example 18, wherein the probe retention structure comprises an aperture.
In Example 20, a system includes a cuvette including a cuvette body having a first cuvette end and a second cuvette end. The cuvette further includes a window frame positioned between the first and second cuvette ends, a window positioned within the window frame, a first probe retention structure positioned near the first cuvette end, and a second probe retention structure extending from the cuvette body and positioned near the second cuvette end. The system further includes a probe having a probe body, a first probe end, and a second probe end. The probe further includes a first cuvette engaging structure near the first probe end, capable of engaging the first probe retention structure, and a second cuvette engaging structure near the second probe end, capable of removably engaging the second probe retention structure.
In Example 21, the system of Example 20, further comprising at least one structure selected from: a first probe retention structure comprising at least one pin, a second probe retention structure comprising at least one aperture, a first cuvette engaging structure comprising at least one bearing surface, and a second cuvette engaging structure comprising at least one protrusion.
While multiple embodiments are disclosed, still other embodiments of the present invention will become apparent to those skilled in the art from the following detailed description, which shows and describes illustrative embodiments of the invention. Accordingly, the drawings and detailed description are to be regarded as illustrative in nature and not restrictive.
While the invention is amenable to various modifications and alternative forms, specific embodiments have been shown by way of example in the drawings and are described in detail below. The intention, however, is not to limit the invention to the particular embodiments described. On the contrary, the invention is intended to cover all modifications, equivalents, and alternatives falling within the scope of the invention as defined by the appended claims.
Blood monitoring equipment may include various sensing elements for measuring properties of venous and/or arterial blood. In some embodiments, it may be desirable to measure hematocrit, oxygen saturation, and temperature, among other parameters of venous blood. Such measurements may be made using a variety of sensor types, including electronic, chemical, optical, etc. For example, hematocrit measurements can be carried out by utilizing LEDs that emit light in a range or set of wavelengths into blood. Blood scatters the emitted light, and characteristics of the scattering can be sensed by an optical sensor and used to provide signals from which the hematocrit level of the blood may be determined. Oxygen saturation also can be measured using an optical sensor. Blood temperature can be measured using infrared sensors, which can measure temperature without contacting blood. In some embodiments, it may be desirable to measure oxygen partial pressure and temperature, among other parameters of arterial blood. Measurements of oxygen partial pressure can be carried out using fluorescence or oxygen quenching, as will described in greater detail below. Like with venous blood, temperature of arterial blood can be measured using infrared sensors. It should be appreciated that sensors providing a wide variation in both signal type (e.g., electronic, optical) and construction may be used in embodiments of the present disclosure.
Referring again to
In one embodiment, the monitor 106 can display measurements taken from various sensors associated with one or more cuvette/probe assemblies. Monitor 106 may also display measurements from other monitoring devices. For example, the monitor 106 may display patient, surgical, and blood measurements and calculated parameters such as temperature, hematocrit, hemoglobin, oxygen delivery, carbon dioxide production, body surface area, and ventilation, among others.
In one embodiment, the window 204 may be made of an optically transmissive polymer such as polyvinilydenefluoride (PVDF) and may be provided with a fluorescent coating or paint. The fluorescent coating can be of a kind sensitive to blood oxygen partial pressure such that the paint changes colors or shades in response to varying oxygen partial pressures. In some embodiments, the entire window may be made of an optically transmissive, biocompatible polymer and no additional coating may be necessary for biocompatibility. The window 204 and window frame 214 in
As shown in
A window retainer 206 shown in
Shown in
Referring again to
The probe 402 may include various sensors, components, and related circuitry for monitoring blood as described above. For example, the probe 402 may include one or more of LEDs, optical sensors, and infrared sensors. In some embodiments, the probe includes an optical sensor that detects color changes of a window coupled to the cuvette 400 and covered with fluorescent coating or paint, which may be sensitive to blood oxygen partial pressure and change colors or shades in response to varying oxygen partial pressures. The probe 402 includes a communication port 412 that can communicatively couple (e.g., electrically or by wireless connection) the probe 402 and a monitor and/or processing equipment, for example.
A first cuvette engaging structure 518 includes a bearing surface 514 to allow probe to engage first probe retention structure (e.g., pins 506) on cuvette 500. As the probe 502 is pivoted on bearing surface 514 around pins 506, the protrusion 510 contacts a portion 516 of the second probe retention structure 504 and compresses the spring assembly 512 such that the protrusion 510 recesses, at least partially, into the probe 502. Once the protrusion 510 aligns with the aperture 508, the spring assembly 512 decompresses and biases the protrusion 510 into the aperture 508 to couple the cuvette 500 and probe 502. In other embodiments, the second probe retention structure (e.g., flange 504) on the cuvette 500 may comprise other features, such as an indent rather than an aperture, to facilitate engagement with the second cuvette engaging structure on probe 502. The spring assembly 512 provides a sufficient spring force to maintain coupling between the probe 502 and cuvette 500 when engaged but also permits the probe 502 to disengage when desired. The probe 502 and its features, first probe retention structure (e.g., pins 506) and its features, and second prove retention structure (e.g., flange 504) are positioned relative to each other such that, when the probe 502 is coupled to the cuvette 500, air does not interfere with blood parameter measurements, which could cause inaccurate blood parameter measurements.
Various modifications and additions can be made to the exemplary embodiments discussed without departing from the scope of the present invention. For example, while the embodiments described above refer to particular features, the scope of this invention also includes embodiments having different combinations of features and embodiments that do not include all of the described features. Accordingly, the scope of the present invention is intended to embrace all such alternatives, modifications, and variations as fall within the scope of the claims, together with all equivalents thereof.
This application is a continuation of U.S. patent application Ser. No. 16/309,065, filed Dec. 11, 2018, which is a National Stage Application of PCT/IB2016/053520, filed Jun. 15, 2016, the entirety of which are incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
3868707 | Bahnsen | Feb 1975 | A |
3936196 | Wickersheim | Feb 1976 | A |
4444498 | Heinemann | Apr 1984 | A |
4447150 | Heinemann | May 1984 | A |
4640820 | Cooper | Feb 1987 | A |
4745279 | Karkar et al. | May 1988 | A |
5289255 | Mullin | Feb 1994 | A |
5304492 | Klinkhammer | Apr 1994 | A |
5314723 | Dutta et al. | May 1994 | A |
5335658 | Bedingham | Aug 1994 | A |
5339375 | Kerns | Aug 1994 | A |
5351686 | Steuer et al. | Oct 1994 | A |
5463466 | Svendsen | Oct 1995 | A |
5628310 | Rao | May 1997 | A |
5641458 | Shockley, Jr. et al. | Jun 1997 | A |
D409750 | Hacker | May 1999 | S |
D410086 | Hacker et al. | May 1999 | S |
5944660 | Kimball et al. | Aug 1999 | A |
6009339 | Bentsen et al. | Dec 1999 | A |
6101406 | Hacker et al. | Aug 2000 | A |
6143247 | Sheppard, Jr. et al. | Nov 2000 | A |
6144444 | Haworth et al. | Nov 2000 | A |
6184526 | Kohama et al. | Feb 2001 | B1 |
7468033 | Van Antwerp et al. | Dec 2008 | B2 |
7481787 | Gable et al. | Jan 2009 | B2 |
8743354 | Barrett | Jun 2014 | B2 |
8842274 | Harnack et al. | Sep 2014 | B2 |
9370324 | Barrett et al. | Jun 2016 | B2 |
9801993 | Barrett et al. | Oct 2017 | B2 |
20010036039 | Yamamoto | Nov 2001 | A1 |
20020005352 | Offenbacher | Jan 2002 | A1 |
20020051979 | Chen et al. | May 2002 | A1 |
20030190262 | Blazewicz | Oct 2003 | A1 |
20040001618 | Johnson et al. | Jan 2004 | A1 |
20040249593 | Dunleavy | Dec 2004 | A1 |
20050035983 | Cruchon-Dupeyrat et al. | Feb 2005 | A1 |
20050215946 | Hansmann | Sep 2005 | A1 |
20060029979 | Bai | Feb 2006 | A1 |
20070073160 | Imam | Mar 2007 | A1 |
20070230859 | Bock et al. | Oct 2007 | A1 |
20090216097 | Wilson | Aug 2009 | A1 |
20110317171 | Emtman et al. | Dec 2011 | A1 |
20120029329 | Braig | Feb 2012 | A1 |
20120218541 | Barrett et al. | Aug 2012 | A1 |
20130171614 | Taccini | Jul 2013 | A1 |
20130203172 | Wex et al. | Aug 2013 | A1 |
20150136961 | Eddy et al. | May 2015 | A1 |
20160370172 | Christoph et al. | Dec 2016 | A1 |
20210196881 | Walls | Jul 2021 | A1 |
20220175416 | Ebnet | Jun 2022 | A1 |
Number | Date | Country |
---|---|---|
205430252 | Aug 2016 | CN |
107582070 | Jan 2018 | CN |
0510377 | Oct 1992 | EP |
2801852 | Nov 2014 | EP |
H0414669 | Jan 1992 | JP |
H04131770 | Dec 1992 | JP |
H0835927 | Feb 1996 | JP |
H09500721 | Jan 1997 | JP |
2001513675 | Sep 2001 | JP |
2008536140 | Sep 2008 | JP |
9427495 | Dec 1994 | WO |
9837801 | Sep 1998 | WO |
2006109282 | Oct 2006 | WO |
WO-2013006716 | Jan 2013 | WO |
WO-2020006549 | Jan 2020 | WO |
Entry |
---|
International Search Report and Written Opinion received for International Application No. PCT/IB2016/053520, dated Apr. 4, 2017, 15 pages. |
Number | Date | Country | |
---|---|---|---|
20220099560 A1 | Mar 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16309065 | US | |
Child | 17545620 | US |